Article

Proteomics analysis in urinary bladder cancer patients identifies urinary SOD2 as a predictive marker of recurrence

2021-12-14

Abstract excerpt

Early non-invasive detection of tumor is an urgent clinical need for managing urothelial bladder cancer. Cystoscopy and cytology are the current standards for diagnosis of recurrence, but are limited by low sensitivity. Quantitative proteomics tool was employed to identify important deregulated molecules in bladder cancer tissues and validated using Western blot and immunohistochemistry analysis. A set of 1137 pro...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c429fc41-1be0-5e64-ab5a-3aad00318448
DOI: 10.1101/2021.12.13.21267125

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Proteomics analysis in urinary bladder cancer patients identifies urinary SOD2 as a predictive marker of recurrenceDOI 10.1101/2021.12.13.21267125Read

Proteomics and genomics of urinary bladder cancer.Semantic proximity Read

A systematic review on diagnostic and prognostic biomarkers for bladder cancerSemantic proximity Read

Proteomics as a Complementary Technique to Characterize Bladder CancerSemantic proximity Read

Recent Advances in the Diagnosis and Management of Bladder Cancer.Semantic proximity Read

STAG2 Coupled With p53 Alteration Has a Significant Impact on Bladder Cancer Recurrence and ProgressionSemantic proximity Read

Improving diagnostic molecular tests to monitor urothelial carcinoma recurrence.Semantic proximity Read

Correlation of BRCA2 gene mutation and prognosis as well as variant genes in invasive urothelial carcinoma of the bladder.Semantic proximity Read

Quantitative Proteomics of Urinary Bladder Cancer Cell Lines Identify UAP1 as a Potential Therapeutic TargetSemantic proximity Read

Identification of Model Based on Oxidative Stress-related Genes for Predicting Prognosis and Therapeutic Features in Bladder CancerSemantic proximity Read

A Comprehensive Investigation toward the Indicative Proteins of Bladder Cancer in Urine: From Surveying Cell Secretomes to Verifying Urine ProteinsSemantic proximity Read

TP53 Mutation for Prediction of Tumor Recurrence and Metastasis in Bladder Cancer PatientsSemantic proximity Read

DNA Microarray Expression Profiling of Bladder Cancer Allows Identification of Noninvasive Diagnostic MarkersSemantic proximity Read